Tonix Pharmaceuticals Holding Corp (TNXP)
R&D Expenses
$63.86M
TTM · Period ending: · USD
TNXP R&D Expenses
Latest reported$63.86Mperiod ending
Latest reported$63.86Mperiod ending
TNXP R&D Expenses ($0.00 → $63.86M)
Annual R&D Expenses
High-resolution chart · PNG
TNXP r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 44,486,000 | |
| 40,448,000 | |
| 86,655,000 | |
| 81,876,000 | |
| 68,838,000 | |
| 36,157,000 | |
| 18,192,000 | |
| 17,558,000 | |
| 13,342,000 | |
| 28,533,000 | |
| 35,504,000 | |
| 18,617,000 | |
| 4,650,000 | |
| 2,583,308 | |
| 1,158,167 | |
| 0 | |
| 0 | |
| 0 |